BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#246 of 347

Leland Gershell

Oppenheimer · Equity Research Analyst
ProvisionalRating since 2020No new ratings since Jun 2025

Analyst rating accuracy & track record

Leland Gershell is an equity research analyst at Oppenheimer. Bullish Whales has scored 36 of their stock calls across 18 companies. Their picks beat their sector 35% of the time over the next 12 months, and their price targets were reached 26% of the time within a year.

Win % vs sector
35%
PT Hit % (12mo)
26%
Avg sector-excess
−13.0%
Scored calls
36
Tickers
18
Tier
Provisional

Track record

Bullish Whales has scored 36 of Leland Gershell's stock calls across 18 companies, dating back to 2020. Their rated stocks beat their own sector 35% of the time over the next 12 months. On a typical call, a Gershell pick returned −13.0% more than its sector over the following year.

Of the scored calls, 36 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
URGNUroGen Pharma Ltd
Buy$10.00Jun 2025+428.0%Hit
XERSXeris Pharmaceuticals Inc
Buy$7.00May 2025+17.0%Hit
QNCXQuince Therapeutics, Inc.
Buy$10.00Mar 2025−94.7%Miss
TRVITrevi Therapeutics Inc
Buy$20.00Mar 2025+82.0%Miss
VERUVeru Inc
Buy$5.00Nov 2024−65.7%Miss
IMVTImmunovant Inc
Buy$53.00Oct 2024−37.7%Miss
CAPRCapricor Therapeutics Inc
Buy$43.00Sep 2024−23.9%Miss
ENGNenGene Holdings Inc. Common Stock
Buy$30.00Sep 2024+20.7%Miss
CAPRCapricor Therapeutics Inc
Buy$15.00Sep 2024−22.9%Hit
CAPRCapricor Therapeutics Inc
Buy$15.00Sep 2024+28.9%Hit
NCNANuCana PLC
Buy$25.00Sep 2024−88.4%Miss
ENGNenGene Holdings Inc. Common Stock
Buy$30.00Aug 2024−16.7%Miss
NCNANuCana PLC
Buy$150.00Aug 2024−89.9%Miss
TARAProtara Therapeutics Inc
Buy$25.00Aug 2024+72.5%Miss
NCNANuCana PLC
Buy$150.00Jul 2024−91.0%Miss
NCNANuCana PLC
Buy$150.00Jul 2024−90.0%Miss
CPRXCatalyst Pharmaceuticals Inc
Buy$29.00Jun 2024+72.4%Miss
TARAProtara Therapeutics Inc
Buy$30.00Apr 2024+34.2%Miss
AVTXAvalo Therapeutics Inc
Buy$35.00Apr 2024−66.0%Miss
VERUVeru Inc
Buy$5.00Apr 2024−59.0%Miss
CUECue Biopharma
Buy$10.00Apr 2024−60.2%Miss
NCNANuCana PLC
Buy$4.00Apr 2024−85.5%Miss
XERSXeris Pharmaceuticals Inc
Buy$5.00Mar 2024+160.5%Hit
CPRXCatalyst Pharmaceuticals Inc
Buy$29.00Mar 2024+56.1%Miss
CPRXCatalyst Pharmaceuticals Inc
Buy$30.00Dec 2023+24.9%Miss
NCNANuCana PLC
Buy$4.00Nov 2023−100.1%Miss
PDSBPDS Biotechnology Corp
Buy$20.00Nov 2023−80.0%Miss
NCNANuCana PLC
Buy$4.00May 2023−99.0%Miss
MISTMilestone Pharmaceuticals Inc
Buy$13.00Apr 2023−59.6%Miss
XFORX4 Pharmaceuticals Inc
Buy$4.00Mar 2023+68.2%Miss
VERUVeru Inc
Buy$9.00Mar 2023−84.1%Miss
VERUVeru Inc
Buy$14.00Feb 2023−101.4%Miss
VERUVeru Inc
Buy$36.00Apr 2022−90.7%Miss
TARAProtara Therapeutics Inc
Buy$34.00Nov 2021−67.9%Miss
WINTWindtree Therapeutics Inc
Buy$8.00Jun 2021−90.7%Miss
VCNXVaccinex Inc
Buy$7.00Sep 2020−6.3%Hit
Go to

Leland Gershell: analyst track record FAQ

Is Leland Gershell a good stock analyst?

Yes, by track record. Leland Gershell ranks number 246 of 347 of the analysts Bullish Whales scores, with a BW Score of 11 out of 100. Past results do not guarantee future ones.

What is Leland Gershell's win rate?

Leland Gershell's win rate is 35%. Across 36 scored calls, their rated stocks beat their sector 35% of the time over the next 12 months. On a typical call they returned −13.0% more than the sector.

What stocks and sectors does Leland Gershell cover?

Leland Gershell covers 18 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Leland Gershell's price targets accurate?

Leland Gershell's price targets are reached within 12 months 26% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Leland Gershell's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Leland Gershell rank among Wall Street analysts?

Leland Gershell ranks number 246 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30